5M58 image
Deposition Date 2016-10-20
Release Date 2017-02-15
Last Version Date 2024-05-08
Entry Detail
PDB ID:
5M58
Keywords:
Title:
Crystal structure of CouO, a C-methyltransferase from Streptomyces rishiriensis
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.05 Å
R-Value Free:
0.26
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:C-methyltransferase CouO
Gene (Uniprot):couO
Chain IDs:A, B
Chain Length:230
Number of Molecules:2
Biological Source:Streptomyces rishiriensis
Ligand Molecules
Primary Citation
Crystal Structure and Catalytic Mechanism of CouO, a Versatile C-Methyltransferase from Streptomyces rishiriensis.
PLoS ONE 12 e0171056 e0171056 (2017)
PMID: 28152088 DOI: 10.1371/journal.pone.0171056

Abstact

Friedel-Crafts alkylation of aromatic systems is a classic reaction in organic chemistry, for which regiospecific mono-alkylation, however, is generally difficult to achieve. In nature, methyltransferases catalyze the addition of methyl groups to a wide range of biomolecules thereby modulating the physico-chemical properties of these compounds. Specifically, S-adenosyl-L-methionine dependent C-methyltransferases possess a high potential to serve as biocatalysts in environmentally benign organic syntheses. Here, we report on the high resolution crystal structure of CouO, a C-methyltransferase from Streptomyces rishiriensis involved in the biosynthesis of the antibiotic coumermycin A1. Through molecular docking calculations, site-directed mutagenesis and the comparison with homologous enzymes we identified His120 and Arg121 as key functional residues for the enzymatic activity of this group of C-methyltransferases. The elucidation of the atomic structure and the insight into the catalytic mechanism provide the basis for the (semi)-rational engineering of the enzyme in order to increase the substrate scope as well as to facilitate the acceptance of SAM-analogues as alternative cofactors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures